Embattled German conglomerate Bayer, which reduced its workforce by 3,200 positions in the first half of the year, has reportedly announced further layoffs this week as it continues to navigate its financial and operational challenges. In a setback for Aadi, the company's plans to widen the use of its key drug were derailed by disappointing results from a phase II solid tumor trial. Meanwhile, on the regulatory front, the FDA has approved updated COVID-19 vaccines that target KP.2 strain to enhance protection this fall. Additionally, Johnson & Johnson made headlines by expanding its MedTech cardiovascular portfolio through a new acquisition, marking a significant move in its growth strategy.
Let's dive into the details.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.